TAK - Company ID 0001395064
TAKEDA PHARMACEUTICAL CO LTD has filed 609 public company documents between 2007 and 2026. The most frequent type is 6-k (323 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 6-K | 6-K | 6mo ago2025-12-18 | 2025-12-18 | View filing |
| 144 | Insider sale notice | 7mo ago2025-12-09 | - | View filing |
| 4 | Insider trade | 7mo ago2025-12-09 | 2025-12-08 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 7mo ago2025-12-09 | - | View filing |
| 6-K | 6-K | 7mo ago2025-12-08 | 2025-12-08 | View filing |
| 144 | Insider sale notice | 7mo ago2025-12-05 | - | View filing |
| 144 | Insider sale notice | 7mo ago2025-12-04 | - | View filing |
| 6-K | 6-K | 7mo ago2025-11-28 | 2025-11-28 | View filing |
| 13F-HR | Institutional holdings | 7mo ago2025-11-13 | 2025-09-30 | View filing |
| 6-K | 6-K | 8mo ago2025-10-30 | 2025-10-30 | View filing |
| 6-K | 6-K | 8mo ago2025-10-30 | 2025-10-30 | View filing |
| 6-K | 6-K | 8mo ago2025-10-30 | 2025-10-30 | View filing |
| 6-K | 6-K | 9mo ago2025-10-01 | 2025-10-01 | View filing |
| 6-K | 6-K | 9mo ago2025-09-25 | 2025-09-25 | View filing |
| 4 | Insider trade | 9mo ago2025-09-19 | 2025-09-17 | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 9mo ago2025-09-19 | - | View filing |
| 6-K | 6-K | 10mo ago2025-09-08 | 2025-09-08 | View filing |
| N-PX | N-PX | 10mo ago2025-08-21 | 2025-08-20 | View filing |
| 13F-HR | Institutional holdings | 11mo ago2025-08-08 | 2025-06-30 | View filing |
| 6-K | 6-K | 11mo ago2025-07-31 | 2025-07-31 | View filing |
| 6-K | 6-K | 11mo ago2025-07-30 | 2025-07-30 | View filing |
| 6-K | 6-K | 12mo ago2025-07-14 | 2025-07-14 | View filing |
| 144 | Insider sale notice | 1y ago2025-07-09 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-07-09 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-07-09 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-07-09 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-07-09 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-07-09 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-07-09 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-07-09 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-07-09 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-07-09 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-07-09 | - | View filing |
| 144 | Insider sale notice | 1y ago2025-07-09 | - | View filing |
| 6-K | 6-K | 1y ago2025-07-09 | 2025-07-09 | View filing |
| 6-K | 6-K | 1y ago2025-07-08 | 2025-07-08 | View filing |
| 6-K | 6-K | 1y ago2025-07-02 | 2025-07-02 | View filing |
| 6-K | 6-K | 1y ago2025-07-01 | 2025-07-01 | View filing |
| 6-K | 6-K | 1y ago2025-06-30 | 2025-06-30 | View filing |
| 424B2 | Prospectus supplement | 1y ago2025-06-27 | - | View filing |
| FWP | Free writing prospectus | 1y ago2025-06-27 | - | View filing |
| 424B5 | Prospectus supplement | 1y ago2025-06-26 | - | View filing |
| F-3ASR | F-3ASR | 1y ago2025-06-25 | - | View filing |
| 20-F | 20-F | 1y ago2025-06-25 | 2025-03-31 | View filing |
| 6-K | 6-K | 1y ago2025-06-25 | 2025-06-25 | View filing |
| 6-K | 6-K | 1y ago2025-06-25 | 2025-06-25 | View filing |
| 6-K | 6-K | 1y ago2025-06-12 | 2025-06-12 | View filing |
| 6-K | 6-K | 1y ago2025-06-10 | 2025-06-10 | View filing |
| 6-K | 6-K | 1y ago2025-06-06 | 2025-06-06 | View filing |
| 6-K | 6-K | 1y ago2025-06-02 | 2025-06-02 | View filing |